Epithelioid sarcomas (ES) are malignant tumors with mixed differentiation of both mesenchymal and epithelial cell types, with up to 90% of cases demonstrating a loss of integrase interactor-1 (INI-1) expression. Here, SMARCB1 is linked to cancer.